Browsing by Author "Vaca Plazarte, Jose Luis"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    "Manejo de síndrome antifosfolípido en el embarazo y prevención de complicaciones materno-fetales”
    (Universidad Técnica de Ambato - Facultad de Ciencias de la Salud - Carrera de Medicina, 2019-06-01) Vaca Plazarte, Jose Luis; Belalcázar Sánchez, Yajaira Monserrath Dra. Esp.
    A 37-year-old female patient with a personal pathological history of antiphospholipid syndrome diagnosed 7 years ago by immunological tests and abortion history on two occasions, without treatment and obesity. Surgical history of a previous caesarean section 7 years ago. Family history of older sister with antiphospholipid syndrome; gynecological-obstetric history: menarche at age 11, beginning of sexual life at 19 years of age, gestations, 4 abortions, 3 deliveries, caesarean section, 1 live births, and PAP test 2 years ago with normal results. CURRENT PREGNANCY: FUM: 05/18/2018 FPP: 02/25/2019 gestational age 37 weeks. Controls 7. Echoes 5. Unplanned pregnancy. Receives calcium 1 gram, acetylsalicylic acid 100 milligrams per day and enoxaparin 40 milligrams subcutaneous day from week 19 of gestation. Patient captured by referral from the first level of health care at 22.5 weeks. At the moment asymptomatic without reporting discomfort. Abdomen: pregnant womb uterine height of 25 centimeters, single live fetus, cephalic, right back, fetal heart rate of 146 bpm, negative uterine activity. Inguinogenital region: there is no evidence of leucorrhoea or genital bleeding. Acetylsalicylic acid 100 mg orally is maintained every day with calcium 2 grams orally every day, enoxaparin 60 mg subcutaneous daily and ferrous sulfate 100 milligrams day; Follow-up is continued by external consultation without complications, she comes to consultation at 37.2 weeks of pregnancy, referring abdominal pain of moderate intensity, her admission is decided for the end of pregnancy, which is carried out without complications by caesarean section obtaining a live newborn without complications , after completing 48 hours of post-surgical observation, patient withdraws in good conditions with newborn and indicated with enoxaparin 60 milligrams subcutaneous daily for 5 days and control by external consultation.